Measuring HPV E7 mRNA in Cervical Samples
Author Information
Author(s): Michael E. Scheurer, Laura M. Dillon, Zhuo Chen, Michele Follen, Karen Adler-Storthz
Primary Institution: The University of Texas M. D. Anderson Cancer Center
Hypothesis
Are there quantitative differences in the expression of E7 mRNA in cells from women with normal epithelium and precancerous lesions?
Conclusion
The study demonstrates that using SYBR-based real-time PCR assays allows for low-cost, high-throughput analysis of HPV E7 mRNA expression, which could improve cervical cancer screening programs.
Supporting Evidence
- 87% of the analyzed samples showed the presence of E7 mRNA.
- The assay demonstrated a coefficient of variation of 10.4%, indicating high reproducibility.
- The method allows for direct comparison of E7 mRNA levels without the need for a reference gene.
Takeaway
The researchers found a way to measure a virus's genetic material in cervical samples, which can help doctors figure out who might get cervical cancer.
Methodology
The study used absolute quantitative real-time PCR with SYBR-green fluorescence to measure HPV E7 mRNA in cervical cytobrush specimens.
Potential Biases
Potential bias may arise from the selection of participants with abnormal Pap test results.
Limitations
The study is limited by the small sample size and the specific focus on HPV types 16 and 18.
Participant Demographics
Women with abnormal Pap test results attending colposcopy clinics.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website